Sino-American Cancer Foundation, Covina, CA, 91722, USA.
Ph.D. Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, 250 Wu-Hsing Street, Taipei, 110301, Taiwan.
Sci Rep. 2023 Nov 14;13(1):19899. doi: 10.1038/s41598-023-47284-5.
The impact of N221S mutation in hRRM2B gene, which encodes the small subunit of human ribonucleotide reductase (RNR), on RNR activity and the pathogenesis of mitochondrial DNA depletion syndrome (MDDS) was investigated. Our results demonstrate that N221 mutations significantly reduce RNR activity, suggesting its role in the development of MDDS. We proposed an allosteric regulation pathway involving a chain of three phenylalanine residues on the αE helix of RNR small subunit β. This pathway connects the C-terminal loop of β2, transfers the activation signal from the large catalytic subunit α to β active site, and controls access of oxygen for radical generation. N221 is near this pathway and likely plays a role in regulating RNR activity. Mutagenesis studies on residues involved in the phenylalanine chain and the regulation pathway were conducted to confirm our proposed mechanism. We also performed molecular dynamic simulation and protein contact network analysis to support our findings. This study sheds new light on RNR small subunit regulation and provides insight on the pathogenesis of MDDS.
我们研究了 hRRM2B 基因(编码人核苷酸还原酶(RNR)小亚基)中的 N221S 突变对 RNR 活性和线粒体 DNA 耗竭综合征(MDDS)发病机制的影响。我们的结果表明,N221 突变显著降低了 RNR 活性,提示其在 MDDS 发生发展中的作用。我们提出了一种涉及 RNR 小亚基β的αE 螺旋上三个苯丙氨酸残基的变构调节途径。该途径连接β2 的 C 末端环,将激活信号从大催化亚基α传递到β活性位点,并控制用于自由基生成的氧气进入。N221 靠近该途径,可能在调节 RNR 活性中发挥作用。我们还进行了涉及苯丙氨酸链和调节途径的残基的诱变研究,以证实我们提出的机制。我们还进行了分子动力学模拟和蛋白质接触网络分析来支持我们的发现。这项研究为 RNR 小亚基调节提供了新的视角,并为 MDDS 的发病机制提供了深入的了解。